Australian drug trends 2026 tell a familiar story. Methamphetamine and heroin remain easy to buy, people keep using them for years, and the road out of addiction is still blocked for many who want to take it. The numbers come from the National Drug and Alcohol Research Centre at UNSW Sydney. Its 2026 Illicit Drug Reporting System findings draw on interviews with 902 people who regularly inject drugs.

The researchers are upfront about the limits. Interviews ran from May to July in every capital city. Participants came through needle and syringe programmes and peer referral. The authors state that the results do not represent all people who inject drugs, or the wider population. Even so, this survey has tracked the same kind of group for years. That makes the shifts from one year to the next worth reading.

Australian Drug Trends 2026 Show Little Movement in Use

Methamphetamine sits at the centre of the picture. In 2026, 81 per cent of participants reported recent use, on a median of 90 days over six months. Crystal made up almost all of it at 79 per cent. The report notes that recent use rose gradually between 2010 and 2021 and has stayed relatively stable since.

Heroin tells a harder story. Half of the sample (51 per cent) reported recent use, which matches last year. But people are using it more often. The median jumped from 120 days in 2025 to 180 days in 2026, a statistically significant rise. Meanwhile, 44 per cent named methamphetamine as their drug of choice and 41 per cent named heroin.

Many also mix substances. On the day before their interview, 63 per cent had taken two or more drugs, not counting tobacco and electronic cigarettes. Three fifths (60 per cent) had binged on at least one drug for 48 hours or more in the previous six months. About one in five (19 per cent) had survived a non fatal overdose in the past year.

Supply Stays Easy and Cheap

Australian drug trends 2026 suggest that getting hold of drugs is not difficult. Ninety six per cent of crystal users described it as easy or very easy to obtain. Heroin scored 95 per cent. Cocaine availability moved sharply, with 79 per cent calling it easy or very easy, up from 62 per cent last year. A point of crystal or heroin still costs a median of $50.

Dealing has also stayed personal. Face to face purchasing was the most popular method in the past year at 84 per cent, up from 79 per cent in 2025.

Dependence and Hardship Sit Side by Side

The dependence scores in Australian drug trends 2026 deserve attention. Among recent opioid users, 66 per cent scored at a level that suggests possible dependence, up from 59 per cent. Among recent methamphetamine users, 47 per cent scored that way, down from 54 per cent, though still close to half.

The wider picture is just as heavy. The median age of participants was 47, so this is not a group of newcomers. Eighty nine per cent were unemployed and 19 per cent had no fixed address. More than half (53 per cent) reported a mental health problem, and 63 per cent recorded high or very high psychological distress. Lifetime incarceration reached 57 per cent. One third also had a drug related encounter with police that ended without arrest or charge.

Where Is the Recovery Pathway?

Here the data raises its sharpest questions. Only 37 per cent of participants were in any drug treatment at the time of interview. Methadone accounted for 21 per cent and buprenorphine depot injections for 9 per cent. Drug counselling reached just 4 per cent.

Another 11 per cent had tried to get treatment in the past six months and could not. Most were seeking help with methamphetamine (55 per cent) or heroin (35 per cent). The services they tried hardest to reach were rehabilitation or therapeutic communities (39 per cent) and detoxification (26 per cent). Asked why they failed, 45 per cent said it was too hard to get in, with no places available or a long waiting list. Another 16 per cent pointed to a lack of support.

Mental health care shows a similar gap in Australia’s illicit drug trends. Of the 53 per cent who reported a mental health problem, about half sought treatment (27 per cent of the whole sample) and about half did not (26 per cent).

Naloxone awareness sits at 79 per cent, so emergency response knowledge has spread. Yet knowing how to reverse an overdose does nothing to help someone stop using in the first place.

What Australian Drug Trends 2026 Cannot Show

This survey counts people who already inject. By design, it cannot say how many Australians were helped before they started, and nothing in its findings points to fewer people reaching this point. The only falls recorded are in cannabis, where recent use dropped to 61 per cent, the lowest in 20 years, and in non prescribed pharmaceutical stimulants (5 per cent) and new psychoactive substances (4 per cent).

The report does capture the end of the line, and Australian drug trends 2026 are blunt about it. Participants arrive at a median age of 47 after years of use, with unstable housing, poor mental health and a justice system history. The treatment figures show that the help most of them need, a place in rehab or detox and ongoing support, is the help they struggle to find.

For anyone reading Australian drug trends 2026 as a scorecard, the gap is plain. Use is steady, supply is easy and recovery services are hard to reach. Closing that gap would need earlier action before use begins and more places for those ready to stop.

Source: unsw